BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32551907)

  • 1. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma.
    Lee EYP; An H; Tse KY; Khong PL
    AJR Am J Roentgenol; 2020 Aug; 215(2):305-312. PubMed ID: 32551907
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis.
    An H; Lee EYP; Chiu K; Chang C
    Clin Radiol; 2018 Jul; 73(7):597-609. PubMed ID: 29685803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
    Roze JF; Hoogendam JP; van de Wetering FT; Spijker R; Verleye L; Vlayen J; Veldhuis WB; Scholten RJ; Zweemer RP
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012567. PubMed ID: 30298516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
    Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
    Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
    Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma.
    Lee EYP; An H; Perucho JAU; Chiu KWH; Hui ES; Chu MMY; Ngan HYS
    Eur Radiol; 2020 Oct; 30(10):5551-5559. PubMed ID: 32405751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
    Delvallée J; Rossard L; Bendifallah S; Touboul C; Collinet P; Bricou A; Huchon C; Lavoue V; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101867. PubMed ID: 32663654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of
    Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
    Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
    Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
    Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinomatosis: role of (18)F-FDG PET.
    Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
    J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women.
    Sponholtz SE; Mogensen O; Hildebrandt MG; Jensen PT
    Acta Obstet Gynecol Scand; 2020 Feb; 99(2):186-195. PubMed ID: 31505027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
    Dubreuil J; Giammarile F; Rousset P; Rubello D; Colletti PM; Glehen O; Skanjeti A
    Nucl Med Commun; 2017 Jan; 38(1):1-9. PubMed ID: 27820721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse peritoneal carcinomatosis and Sister Mary Joseph nodule in ovarian carcinoma - exquisite demonstration of the peritoneal reflections on [18F]FDG PET/CT.
    Robinson E; Nawwar A; Searle J; Lyburn I
    Nucl Med Rev Cent East Eur; 2023; 26(0):153-155. PubMed ID: 37991329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
    Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
    Amit A; Hodes A; Lavie O; Keidar Z; Matanes E; Lowenstein L
    Surg Oncol; 2017 Dec; 26(4):347-351. PubMed ID: 29113651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.